Sarepta Therapeutics Inc at Robert W Baird Global Healthcare Conference Transcript
Okay. Hello, everyone. Thanks for joining us this afternoon at Baird's Virtual Health Care Conference, I'm Brian Skorney, I'm one of senior biotech analysts here. Joining us virtually next is the management team from Sarepta Therapeutics. It's a really exciting company. I've been following it for a number of years. I'll let them introduce themselves and the company to all of you before we get into more of a Q&A session. So maybe to start off, Doug, if you could give us a little bit of a background around Sarepta's history and where you guys are focused on right now?
Sure. Thanks a lot, Brian. Thanks for having us today. Two things, one, I'm supposed to remind you that I will -- you'll likely ask me questions that will require me to make forward-looking statements. You should look at our public filings about the risks and uncertainties attended with that. I am the CEO of Sarepta
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
